On June 20, 2024, founder Dr. Zahra Kashi and senior management partnered with Prairie Capital to recapitalize Kashi Clinical Laboratories. Headquartered in Portland, OR, Kashi Clinical Laboratories is a fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals, long-term care facilities, and transplant centers around the world.
The company was founded in 2006 to provide high-resolution HLA typing for transplant donor matching. Over time, Kashi expanded its service offerings to include post-transplant monitoring, genomic sequencing, and other diagnostic testing. Kashi enjoys industry-leading customer satisfaction and is renowned for its rapid turnaround time, scientific expertise, customer service, and innovation using state-of-the-art technology.
Kashi Clinical Laboratories partnered with Prairie to accelerate growth through strategic investments in human capital, sales and marketing, technology, infrastructure, new services, and add-on acquisitions.
For more information, please contact:
Dena Balbach
Chief Business Officer
503-206-4989
dbalbach@kashilab.com
www.kashilab.com
